Bayer and Rad AI Announce Collaboration agreement
27 Junio 2024 - 9:15AM
Business Wire
Collaboration brings together Rad AI’s
generative AI radiology reporting solutions and patient follow-up
management solution with Bayer’s Calantic™ Digital Solution
Platform
As experts from around the globe gather at the annual Society
for Informatics in Medicine (SIIM) conference, Bayer and Rad AI are
announcing a collaboration to bring Rad AI’s cutting edge AI
radiology operational solutions to Calantic ™ Digital Solution
customers.
Rad AI’s radiology speech recognition reporting solution,
AI-driven patient follow-up management, and automated radiology
impression generation technologies complement Bayer’s Calantic™
Digital Solutions platform, enabling more hospitals and health
systems to benefit from Rad AI’s generative AI capabilities.
Imaging data accounts for about 90 percent of all healthcare
data1, and the number of images continues to grow, increasing the
workload for radiologists on top of resource constraints. At the
same time there is a growing need to demonstrate value from AI
deployments. This collaboration enables Radiology suites to take
advantage of operational Radiology AI applications and a scalable
deployment platform integrated through one vendor.
Rad AI Reporting helps radiologists create reports faster by
using generative AI to organize radiology reports for radiologists
allowing them to focus on reading studies as well as integrating
stable findings from prior reports. Rad AI Omni Impressions
generates customized radiology report impressions from dictated
findings, tailored to each radiologist’s language preferences and
helping to reducing fatigue. Rad AI Continuity automates the
follow-up process for incidental findings, helping to promote
timely patient follow-up, and potentially increasing imaging
revenue for health systems.
Calantic™ Digital Solutions is a suite of digital radiology
AI-enabled clinical and operational applications that assist
radiologists and their teams at critical steps within a patient’s
journey through the Radiology suite. The Calantic platform is a
vendor-neutral, cloud-hosted platform which includes a growing
number of applications designed to aid in prioritization, lesion
detection and quantification, as well as apps that automate routine
tasks, measurements, and improve workflows in Radiology suites. The
platform uses a curation approach to select apps based on
structured assessment criteria.
"Rad AI and Bayer are dedicated to pioneering innovations that
serve hospitals and health systems, allowing for greater access to
these advanced technologies. This relationship allows for expanded
use of our cutting-edge solutions in hospitals across the country,"
Doktor Gurson, co-founder and CEO of Rad AI.
“Our customers consistently convey to us that a clear ROI from
the use of AI will help to increase confidence and adoption.
Demonstrating ROI via operational applications like those on
Bayer’s Calantic™ Digital Solutions platform is often an easier
path, which is why Bayer is excited to enter into this agreement
with Rad AI. This technology has the ability to help physicians
optimize and streamline their radiology reporting, and deliver
benefits for the patient and the health system,” said Rich Dewit,
Senior Vice-President, Digital Solutions, Bayer Radiology.
About Bayer
Bayer is a global enterprise with core competencies in the life
science fields of health care and nutrition. Its products and
services are designed to help people and the planet thrive by
supporting efforts to master the major challenges presented by a
growing and aging global population. Bayer is committed to driving
sustainable development and generating a positive impact with its
businesses. At the same time, Bayer aims to increase its earning
power and create value through innovation and growth. The Bayer
brand stands for trust, reliability, and quality throughout the
world. In fiscal 2022, the Group employed around 99,723 people and
had sales of 50.7 billion euros. R&D expenses before special
items amounted to 6.2 billion euros. For more information, go to
www.bayer.com.
About Rad AI
Rad AI is a radiologist-led AI company. The company has been
recognized as one of the most promising healthcare AI companies by
CB Insights (Digital Health 50, AI 100) and AuntMinnie (Best New
Radiology Software of 2023, Best New Radiology Vendor of 2021). In
Dec 2023, an Accenture report noted that Rad AI has the highest
influence score and brand buzz of any private company in
radiology.
Founded by the youngest US radiologist in history, Rad AI
empowers physicians with Al that can potentially save time, reduce
burnout, and improve the quality of patient care. Rad AI combines
deep expertise in healthcare and AI while building on voluminous
proprietary radiology report datasets.
Forward-Looking Statements
This release may contain forward-looking statements based on
current assumptions and forecasts made by Bayer management. Various
known and unknown risks, uncertainties and other factors could lead
to material differences between the actual future results,
financial situation, development or performance of the company and
the estimates given here. These factors include those discussed in
Bayer’s public reports which are available on the Bayer website at
www.bayer.com. The company assumes no liability whatsoever to
update these forward-looking statements or to conform them to
future events or developments.
1, S. K. Zhou et al., "A Review of Deep Learning in Medical
Imaging: Imaging Traits, Technology Trends, Case Studies With
Progress Highlights, and Future Promises," in Proceedings of the
IEEE, vol. 109, no. 5, pp. 820-838, May 2021, doi:
10.1109/JPROC.2021.3054390.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240627243899/en/
Contact for media inquiries:
Jennifer May, 412-656-8192 Email: jennifer.may@bayer.com
Find more information at https://pharma.bayer.com/ Follow us on
Facebook: http://www.facebook.com/bayer Follow us on X:
@BayerPharma